Multifocal Electroretinography and Optical Coherence Tomography Changes After Repeated Intravitreal Bevacizumab (Avastin) in Myopic Choroidal Neovascularization
Purpose: The purpose of this study was to evaluate the short-term efficacy and safety of repeated intravitreal bevacizumab for myopic choroidal neovascularization. Methods: We performed a prospective, nonrandomized, interventional case series study. Sixteen eyes from 16 patients with myopic choroidal neovascularization secondary to pathologic myopia had a monthly injection of intravitreal bevacizumab 1.25 mg for 3 consecutive months. Best-corrected visual acuity assessment, optical coherence tomography, fluorescein angiography and multifocal electroretinogram were performed before treatment and at 1, 2, 3, and 6 months. Results: The mean logarithm of minimum angle of resolution best-corrected visual acuity was 1.43 before treatment ...
Login to comment.